Melanoma Awareness: Partnering for a Healthier Future

Melanoma Skin Cancer DBS 2024

At Diagnostic BioSystems Inc., we’re committed to advancing the fight against melanoma through innovative diagnostic reagents. As one of the leading manufacturers in this field, we understand the critical role that early detection plays in saving lives.

Immunohistochemistry (IHC) plays a pivotal role in the diagnosis and characterization of melanoma, providing crucial information for clinicians and pathologists.

Several IHC markers are commonly used in the diagnosis and classification of melanoma. These include:

S100: A sensitive marker for melanocytic cells. It’s often used as a first-line marker due to its high sensitivity, but it lacks specificity.

Melan-A (MART-1): A melanocyte-specific marker, useful for confirming the melanocytic origin of a lesion.

HMB-45:Another marker specific to melanocytes, often used alongside Melan-A to confirm melanoma.

SOX10: A highly sensitive marker for melanocytic cells, valuable in diagnosing desmoplastic melanoma, a variant that can be challenging to detect with other markers.

MITF: An additional melanocytic marker that can aid in melanoma diagnosis.

Our reagents are meticulously designed and rigorously tested to deliver precise and reliable results, reducing false positives and negatives.

Looking for USFDA approved CE marked high quality cancer marker for your Melanoma cases? Choose Diagnostic BioSystems for superior performance and confidence in every result.